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Viviany R. Taqueti, MD, MPHI n July 2014, I began work as a cardiologist. Ithappens routinely and without fanfare, but thereis something worthy of pause during one’s tran-
sition to faculty from fellowship training. The world
of health care that I now enter as a cardiovascular
specialist is profoundly different from the one to
which I was exposed as a medical student more
than a decade ago. Uncertainty is everywhere, from
how care should be structured, delivered, and paid
for, to what constitutes appropriate care. The growing
complexity has, paradoxically, but predictably, been
accompanied by diminished institutional commit-
ments to biomedical research. What does this mean
for those of us just emerging from the academic med-
ical pipeline?
As a medical student many years ago, I remember
listening to Professor Eugene Braunwald as he
addressed a crowd of trainees with a precursor to his
lecture on “Adventures in Cardiovascular Research”
(1). I was fascinated. Years later at Brigham and
Women’s Hospital, I had the opportunity to interact
with Dr. Braunwald during fellows’ reports. Between
pages and codes, I heard him tell the stories of the
advent of transbronchial and later transseptal cardiac
catheterization, of deﬁning the natural history of
severe calciﬁc aortic stenosis prior to the adoption of
widespread surgical intervention, of the dramatic
discovery of “functional aortic stenosis” (now known
as hypertrophic obstructive cardiomyopathy) in a
young patient in the operating theater, and of the
realization that carotid sinus stimulation not only
alleviated angina, but also normalized ST-segment
elevation in a patient in the throes of myocardial
infarction, leading to a revolutionary idea in
thrombolysis.From the Heart and Vascular Center and Department of Radiology,
Brigham and Women’s Hospital and Harvard Medical School, Boston,
Massachusetts; and the Cardiology Section, VA Boston Healthcare
System, Boston, Massachusetts. An early version of this perspective was
published in a 2013 conference newsletter of the American Heart
Association (2). This essay has since been updated and altered.The narratives were extraordinary. Speaking in a
low rumble, he was crystal clear, careful to identify
events by the proper chronology and to give credit to
coinvestigators whom he mentioned by their full
names. He referred to his colleagues and their
collective scientiﬁc legacies as his “intellectual
offspring.” He emphasized the importance of
focusing on big questions and the act of choosing a
mentor as the single most consequential decision of
one’s career. He peppered his stories with personal
anecdotes of unlikely collaborations started at the
taxi stand or over dinner at the local housing complex
of the former National Heart Institute. He then neatly
summarized his “10 tips for a successful career in
translational research.”
Effortlessly, industriously, he commanded a crowd,
bringing together generations that included visiting
students and longtime disciples. We listened in
silence, amazed and delighted by the stories. In
them, cardiology became personal. Ancient diagrams
from seminal papers came to life. In our minds, we
contrasted the world he depicted with the more
familiar hospital wards and research laboratories of
our day. Matter-of-factly, he recounted how, at my
age, he served as chief of cardiology and, not long
thereafter, chair of medicine. He talked of days when
institutional review boards and informed consent
did not exist. At its simplest, there was an observa-
tion, and from that careful observation, there were
possibilities.
I recognize now that bearing witness to these
stories was invaluable. For me, these ﬁrsthand
accounts provided context for what we set out to do
every day in academic cardiology. There are few ex-
amples more powerful than hearing Dr. Braunwald
tell of a difﬁcult time and watching him light up as he
described how a perceived mistake blossomed into a
discovery. It provided a humanizing and inspiring
complement to reading about his latest successful
randomized clinical trial.
As many of us wrestle with the future of academic
research in an era of constraints, his words still
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844provide perspective. Trainees of my generation grew
up with the idealism of the academic physician-
scientist as the “triple threat” of master clinician,
scientist, and educator. Listening to Dr. Braunwald,
however, I was reminded that this construct is rela-
tively new, fashioned over the last 6 decades with the
advent of hypothesis-driven research. This opened
up an already rich world of clinical observations to
even richer possibilities afforded by the ready path
from bench to bedside, and back.
These days, it can be difﬁcult to maneuver
the wards or laboratories of academic institutions
without daily reminders of the growing demands
and all-consuming complexities inherent in modern
clinical care, scientiﬁc research, and post-graduate
training. In an increasingly scrutinized clinical envi-
ronment that values volume and, in the near future,
outcomes; an increasingly competitive research
environment that rewards big science while remain-
ing vulnerable to political volatility; and an increas-
ingly strained training environment that defaults
to longer, specialized tracks while simultaneously
limiting hours and hands-on experience, many are
questioning the viability of the path to becoming a
“triple threat.”
But, as Dr. Braunwald noted, as the concept of the
academic physician-scientist evolved previously, it is
evolving again. The profound, perhaps inevitable,
changes under way are providing new opportunitiesfor creative thinking, including better utilization of
available resources by forging new collaborations to
approach existing challenges. As he hinted, the
thrombocardiologist of the 20th century is becoming
the diabetocardiologist of the 21st century, and so on.
Opportunity is here, and those who persevere in
novel ways, guided by an inner compass grounded in
promoting health and healing patients, will make
important contributions.
It is easy to underestimate the impact of these
exchanges on those in the early stages of their ca-
reers. Through often unexpected encounters, I have
enjoyed interacting informally with some of the
greats in our profession, hearing from thought leaders
in unconventional forums as they shared details
about their experiences as they unfolded, sometimes
with surprising results. These reﬂections are critical
for fostering context, conﬁdence, and a sense of
possibility, particularly beyond the conﬁnes of any
local institution. As I transition, I look to those who
have come before me with gratitude for their
example, inspiration, and generosity. For those who
will come after me, I am reminded of this, our re-
sponsibility to inspire possibility.
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